China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Mechanism by Which m6A Modification of circ_104797 Regulates Cisplatin Resistance in Bladder Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133645
Registration Time: 2026/09/30
Type: Observational study
Primary Sponsor: Shenzhen Second People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339893
Published by HT Digital Content Services with permission from Health Daily Digest....